vs
Medline Inc.（MDLN）与Raymond James Financial（RJF）财务数据对比。点击上方公司名可切换其他公司
Medline Inc.的季度营收约是Raymond James Financial的1.9倍（$7.4B vs $3.9B），Raymond James Financial净利率更高（14.1% vs 3.3%，领先10.8%），Raymond James Financial同比增速更快（13.0% vs 10.7%）
Medline Inc.是总部位于美国伊利诺伊州诺斯菲尔德的医疗企业，为美国规模最大的私营医疗用品制造商及分销商，可面向全护理场景提供产品、培训、临床项目及相关服务。2021年6月，公司被黑石、凯雷、赫尔曼&弗里德曼组成的私募财团以340亿美元估值收购，是史上规模最大的杠杆收购案之一。
雷蒙德詹姆斯金融是美国跨国独立投资银行及金融服务机构，通过旗下子公司为个人、企业及市政主体提供多元金融服务，核心业务覆盖投资与财务规划、投资银行、资产管理等领域，总部位于美国佛罗里达州圣彼得堡。
MDLN vs RJF — 直观对比
营收规模更大
MDLN
是对方的1.9倍
$3.9B
营收增速更快
RJF
高出2.3%
10.7%
净利率更高
RJF
高出10.8%
3.3%
损益表 — Q1 FY2026 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $7.4B | $3.9B |
| 净利润 | $239.0M | $544.0M |
| 毛利率 | 25.0% | — |
| 营业利润率 | 5.7% | — |
| 净利率 | 3.3% | 14.1% |
| 营收同比 | 10.7% | 13.0% |
| 净利润同比 | -59.9% | 10.0% |
| 每股收益（稀释后） | $0.16 | $2.72 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDLNRJF
| Q1 26 | $7.4B | $3.9B | ||
| Q4 25 | — | $4.2B | ||
| Q3 25 | — | $4.2B | ||
| Q2 25 | — | $3.8B | ||
| Q1 25 | — | $3.8B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $3.8B |
净利润MDLNRJF
| Q1 26 | $239.0M | $544.0M | ||
| Q4 25 | — | $563.0M | ||
| Q3 25 | — | $604.0M | ||
| Q2 25 | — | $436.0M | ||
| Q1 25 | — | $495.0M | ||
| Q4 24 | — | $600.0M | ||
| Q3 24 | — | $602.0M | ||
| Q2 24 | — | $492.0M |
毛利率MDLNRJF
| Q1 26 | 25.0% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率MDLNRJF
| Q1 26 | 5.7% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 14.7% | ||
| Q1 25 | — | 17.5% | ||
| Q4 24 | — | 18.6% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 17.1% |
净利率MDLNRJF
| Q1 26 | 3.3% | 14.1% | ||
| Q4 25 | — | 13.5% | ||
| Q3 25 | — | 14.4% | ||
| Q2 25 | — | 11.3% | ||
| Q1 25 | — | 12.9% | ||
| Q4 24 | — | 14.9% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | — | 13.1% |
每股收益（稀释后）MDLNRJF
| Q1 26 | $0.16 | $2.72 | ||
| Q4 25 | — | $2.79 | ||
| Q3 25 | — | $2.96 | ||
| Q2 25 | — | $2.12 | ||
| Q1 25 | — | $2.36 | ||
| Q4 24 | — | $2.86 | ||
| Q3 24 | — | $2.85 | ||
| Q2 24 | — | $2.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.2B | $5.4B |
| 总债务越低越好 | $12.5B | — |
| 股东权益账面价值 | $19.3B | $52.0M |
| 总资产 | $39.0B | $91.9B |
| 负债/权益比越低杠杆越低 | 0.65× | — |
8季度趋势，按日历期对齐
现金及短期投资MDLNRJF
| Q1 26 | $2.2B | $5.4B | ||
| Q4 25 | — | $9.9B | ||
| Q3 25 | — | $11.4B | ||
| Q2 25 | — | $9.2B | ||
| Q1 25 | — | $9.7B | ||
| Q4 24 | — | $10.0B | ||
| Q3 24 | — | $11.0B | ||
| Q2 24 | — | $9.1B |
总债务MDLNRJF
| Q1 26 | $12.5B | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益MDLNRJF
| Q1 26 | $19.3B | $52.0M | ||
| Q4 25 | — | $12.6B | ||
| Q3 25 | — | $12.5B | ||
| Q2 25 | — | $12.3B | ||
| Q1 25 | — | $12.2B | ||
| Q4 24 | — | $11.9B | ||
| Q3 24 | — | $11.7B | ||
| Q2 24 | — | $11.2B |
总资产MDLNRJF
| Q1 26 | $39.0B | $91.9B | ||
| Q4 25 | — | $88.8B | ||
| Q3 25 | — | $88.2B | ||
| Q2 25 | — | $84.8B | ||
| Q1 25 | — | $83.1B | ||
| Q4 24 | — | $82.3B | ||
| Q3 24 | — | $83.0B | ||
| Q2 24 | — | $80.6B |
负债/权益比MDLNRJF
| Q1 26 | 0.65× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $412.0M | — |
| 自由现金流经营现金流 - 资本支出 | $316.0M | — |
| 自由现金流率自由现金流/营收 | 4.3% | — |
| 资本支出强度资本支出/营收 | 1.3% | — |
| 现金转化率经营现金流/净利润 | 1.72× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDLNRJF
| Q1 26 | $412.0M | — | ||
| Q4 25 | — | $-10.0M | ||
| Q3 25 | — | $796.0M | ||
| Q2 25 | — | $691.0M | ||
| Q1 25 | — | $117.0M | ||
| Q4 24 | — | $830.0M | ||
| Q3 24 | — | $510.0M | ||
| Q2 24 | — | $711.0M |
自由现金流MDLNRJF
| Q1 26 | $316.0M | — | ||
| Q4 25 | — | $-56.0M | ||
| Q3 25 | — | $752.0M | ||
| Q2 25 | — | $634.0M | ||
| Q1 25 | — | $71.0M | ||
| Q4 24 | — | $789.0M | ||
| Q3 24 | — | $460.0M | ||
| Q2 24 | — | $655.0M |
自由现金流率MDLNRJF
| Q1 26 | 4.3% | — | ||
| Q4 25 | — | -1.3% | ||
| Q3 25 | — | 17.9% | ||
| Q2 25 | — | 16.5% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 11.5% | ||
| Q2 24 | — | 17.4% |
资本支出强度MDLNRJF
| Q1 26 | 1.3% | — | ||
| Q4 25 | — | 1.1% | ||
| Q3 25 | — | 1.1% | ||
| Q2 25 | — | 1.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 1.0% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.5% |
现金转化率MDLNRJF
| Q1 26 | 1.72× | — | ||
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | 1.32× | ||
| Q2 25 | — | 1.58× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 1.38× | ||
| Q3 24 | — | 0.85× | ||
| Q2 24 | — | 1.45× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MDLN
| Supply Chain Solutions segment | $3.9B | 53% |
| Medline Brand segment | $3.5B | 47% |
RJF
| Private Client Group | $2.8B | 73% |
| Bank | $486.0M | 13% |
| Capital Markets | $464.0M | 12% |
| Other | $99.0M | 3% |
